Definition and initial validation of a lupus low disease activity state (LLDAS) K Franklyn, CS Lau, SV Navarra, W Louthrenoo, A Lateef, L Hamijoyo, ... Annals of the rheumatic diseases 75 (9), 1615-1621, 2016 | 692 | 2016 |
Early mortality in a multinational systemic sclerosis inception cohort Y Hao, M Hudson, M Baron, P Carreira, W Stevens, C Rabusa, ... Arthritis & rheumatology 69 (5), 1067-1077, 2017 | 217 | 2017 |
Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study Arthritis Research and Therapy 19 (62), 1-11, 2017 | 148 | 2017 |
Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study V Golder, R Kandane-Rathnayake, M Huq, HT Nim, W Louthrenoo, ... The Lancet Rheumatology 1 (2), e95-e102, 2019 | 139 | 2019 |
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension K Morrisroe, W Stevens, M Huq, D Prior, J Sahhar, GS Ngian, ... Arthritis Research & Therapy 19, 1-10, 2017 | 94 | 2017 |
Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus S Oon, M Huq, V Golder, PX Ong, EF Morand, M Nikpour Annals of the Rheumatic Diseases 78 (5), 629-633, 2019 | 78 | 2019 |
Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus S Oon, M Huq, T Godfrey, M Nikpour Seminars in arthritis and rheumatism 48 (2), 221-239, 2018 | 68 | 2018 |
Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis N Ferdowsi, M Huq, W Stevens, M Hudson, M Wang, T Tay, JL Burchell, ... Annals of the rheumatic diseases 78 (6), 807-816, 2019 | 65 | 2019 |
Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study K Morrisroe, M Huq, W Stevens, C Rabusa, SM Proudman, M Nikpour, ... BMC pulmonary medicine 16, 1-8, 2016 | 64 | 2016 |
Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study V Golder, R Kandane-Rathnayake, M Huq, W Louthrenoo, SF Luo, ... The Lancet Rheumatology 1 (2), e103-e110, 2019 | 62 | 2019 |
Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort V Golder, R Kandane-Rathnayake, AYB Hoi, M Huq, W Louthrenoo, Y An, ... Arthritis research & therapy 18, 1-9, 2016 | 58 | 2016 |
Incidence, risk factors, and outcomes of cancer in systemic sclerosis K Morrisroe, D Hansen, M Huq, W Stevens, J Sahhar, GS Ngian, ... Arthritis care & research 72 (11), 1625-1635, 2020 | 56 | 2020 |
Hospital volume and perioperative outcomes for radical cystectomy: a population study CU Marlon Perera, Molla Huq, Lih-Ming Wong, Daniel Lenaghan BJU International 119 (5), 26-32, 2017 | 42* | 2017 |
AusSCORE II in predicting 30-day mortality after isolated coronary artery bypass grafting in Australia and New Zealand B Billah, MM Huq, JA Smith, F Sufi, L Tran, GC Shardey, CM Reid The Journal of thoracic and cardiovascular surgery 148 (5), 1850-1855. e2, 2014 | 40 | 2014 |
Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosis J Moxey, M Huq, S Proudman, J Sahhar, GS Ngian, J Walker, G Strickland, ... Arthritis research & therapy 21, 1-12, 2019 | 37 | 2019 |
Lupus low disease activity state and reduced direct health care costs in patients with systemic lupus erythematosus AL Yeo, R Koelmeyer, R Kandane‐Rathnayake, V Golder, A Hoi, M Huq, ... Arthritis Care & Research 72 (9), 1289-1295, 2020 | 35 | 2020 |
Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus KL Connelly, R Kandane-Rathnayake, M Huq, A Hoi, M Nikpour, ... Scientific reports 8 (1), 3268, 2018 | 33 | 2018 |
Gender Disparities in Secondary Education in Bangladesh. M Huq, PMM Rahman International Education Studies 1 (2), 115-128, 2008 | 32 | 2008 |
Predicting long-term survival after coronary artery bypass graft surgery BB Md N Karim, Christopher M Reid, Molla Huq, Samuel L Brilleman, Andrew ... Interactive Cardiocascular and Thoracic Surgery, 1-7, 2017 | 31* | 2017 |
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? Journal of Scleroderma and Related Disorders, 2017 | 30 | 2017 |